Bender of Intensity Therapeutics has ideas for cancer research

Lewis Bender is founder, president and CEO of Intenisty Therapeutics. Hee invented the company’s proprietary platform technology — DuseRx — conducting the initial chemistry in his basement.

Less than four and a half years after founding the company, using funding from friends and family, he led a small team that began clinical testing of a new treatment concept. more